Researchers integrating transcriptomic and clinical profiling identified a monocyte-linked peripheral complement remodeling ...

Researchers have identified a promising new target in the treatment of pancreatic cancer. A new study in The American Journal ...

Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the third quarter of 2026 on ...

Canada has signalled that it is in no hurry to loosen its immigration controls. Its newly announced Immigration Levels Plan ...

Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a technology company in defense, national security, and global ...

Findings might help avacopan's fight to stay in the U.S. market ...

To sustain supplies of key metals, policymakers should support the infrastructure needed to deploy mining biotechnologies on ...

On November 9, 2026, in an official blog post, Google announced the General Availability (GA; a formal release available to ...

Retain and Gain planning reform to make it easier for homeowners to subdivide their property while keeping their existing houseProposed reform ...

Determining the appropriate treatment setting is not a one‑time decision,” says Jillian Lampert, PhD, MPH, RD, LD.

Preliminary data from an investigator-initiated Phase 1 study reinforce feasibility and suggest upstream innate-to-Th1 proof ...